Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is a peptide analogue of human GLP-1 designed to provide prolonged pharmacological activity compared with naturally occurring GLP-1.
Liraglutide recombinant API is associated with recombinant DNA-based peptide production and specialized downstream processing. The peptide structure contains modifications that support prolonged biological activity and enhanced stability.
Liraglutide acts as a GLP-1 receptor agonist and is associated with glucose-dependent insulin secretion, glucagon regulation, gastric emptying, and appetite-related physiological pathways. It is used in regulated pharmaceutical products and development programs associated with type 2 diabetes and chronic weight management.
Liraglutide Recombinant API requires stringent control of peptide identity, purity, assay, related peptides, aggregates, biological potency, residual host cell proteins, residual host cell DNA, microbial quality, and bacterial endotoxins.
Swapnroop Drugs and Pharmaceuticals supports Liraglutide Recombinant API sourcing and specialized pharmaceutical raw material requirements for pharmaceutical companies, peptide formulation developers, research organizations, and international buyers. Product specifications and documentation are supplied according to applicable customer, regulatory, and project requirements.
Liraglutide Recombinant API is associated with:
Available documentation may include, subject to product and supply requirements:
Certificate of Analysis – COA
Material Safety Data Sheet – MSDS / SDS
Product Specification Sheet
Analytical Test Report
HPLC Purity Data, where available
Peptide Mapping Data, where available
Mass Spectrometry Data, where available
Residual Host Cell Protein Information, where applicable
Residual Host Cell DNA Information, where applicable
Bacterial Endotoxin Test Information
Storage and Handling Information
Stability Information, where available
Regulatory and technical documentation, subject to agreement
Swapnroop Drugs and Pharmaceuticals is a pharmaceutical raw material supplier based in Maharashtra, India, serving pharmaceutical, peptide, research, and development requirements.
We focus on:
Swapnroop Drugs and Pharmaceuticals supplies and supports Liraglutide Recombinant API requirements for pharmaceutical companies, peptide formulation developers, research organizations, laboratories, and international buyers.
For Liraglutide Recombinant API requirements, customers may contact our team for product availability, specifications, documentation, quantity, packaging, storage conditions, and commercial information.
Company Name: Swapnroop Drugs and Pharmaceuticals
Location: Maharashtra, India
Email: enquiry@sdp.org.in
Website: www.sdp.org.in